BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31231394)

  • 1. The Complement Cascade as a Mediator of Human Malignant Hematopoietic Cell Trafficking.
    Lenkiewicz A; Bujko K; Brzezniakiewicz-Janus K; Xu B; Ratajczak MZ
    Front Immunol; 2019; 10():1292. PubMed ID: 31231394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the complement cascade enhances motility of leukemic cells by downregulating expression of HO-1.
    Abdelbaset-Ismail A; Borkowska-Rzeszotek S; Kubis E; Bujko K; Brzeźniakiewicz-Janus K; Bolkun L; Kloczko J; Moniuszko M; Basak GW; Wiktor-Jedrzejczak W; Ratajczak MZ
    Leukemia; 2017 Feb; 31(2):446-458. PubMed ID: 27451975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive Phospholipids Enhance Migration and Adhesion of Human Leukemic Cells by Inhibiting Heme Oxygenase 1 (HO-1) and Inducible Nitric Oxygenase Synthase (iNOS) in a p38 MAPK-Dependent Manner.
    Abdelbaset-Ismail A; Cymer M; Borkowska-Rzeszotek S; Brzeźniakiewicz-Janus K; Rameshwar P; Kakar SS; Ratajczak J; Ratajczak MZ
    Stem Cell Rev Rep; 2019 Feb; 15(1):139-154. PubMed ID: 30302660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External Liver-Derived Complement and Intrinsic Present in Hematopoietic Stem/Progenitor Cells Complosome Modulate Cell Metabolism and Response to Stress.
    Thapa A; Ratajczak J; Kucia M; Ratajczak MZ
    Stem Cell Rev Rep; 2023 Jul; 19(5):1177-1184. PubMed ID: 36976465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heme Oxygenase 1 (HO-1) as an Inhibitor of Trafficking of Normal and Malignant Hematopoietic Stem Cells - Clinical and Translational Implications.
    Ratajczak MZ; Adamiak M; Ratajczak J; Kucia M
    Stem Cell Rev Rep; 2021 Jun; 17(3):821-828. PubMed ID: 33196976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Emerging Link Between the Complement Cascade and Purinergic Signaling in Stress Hematopoiesis.
    Ratajczak MZ; Adamiak M; Kucia M; Tse W; Ratajczak J; Wiktor-Jedrzejczak W
    Front Immunol; 2018; 9():1295. PubMed ID: 29922299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of Heme Oxygenase 1 (HO-1) Activity in Hematopoietic Cells Enhances Their Engraftment After Transplantation.
    Adamiak M; Moore JB; Zhao J; Abdelbaset-Ismail A; Grubczak K; Rzeszotek S; Wysoczynski M; Ratajczak MZ
    Cell Transplant; 2016; 25(7):1265-76. PubMed ID: 27412411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of a Pivotal Role for the Distal Part of the Complement Cascade in the Diurnal Release of Hematopoietic Stem Cells Into Peripheral Blood.
    Borkowska S; Suszynska M; Ratajczak J; Ratajczak MZ
    Cell Transplant; 2016; 25(2):275-82. PubMed ID: 26087465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling of the Complement Cleavage Product Anaphylatoxin C5a Through C5aR (CD88) Contributes to Pharmacological Hematopoietic Stem Cell Mobilization.
    Bujko K; Rzeszotek S; Hoehlig K; Yan J; Vater A; Ratajczak MZ
    Stem Cell Rev Rep; 2017 Dec; 13(6):793-800. PubMed ID: 28918528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cells on the crossroad between purinergic signaling and innate immunity.
    Franczak S; Ulrich H; Ratajczak MZ
    Purinergic Signal; 2023 May; ():. PubMed ID: 37184740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation in type 1 human diabetes.
    Sundsmo JS; Papin RA; Wood L; Hirani S; Waldeck N; Buckingham B; Kershnar A; Ascher M; Charles MA
    Clin Immunol Immunopathol; 1985 May; 35(2):211-25. PubMed ID: 3907907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a.
    Reed SL; Ember JA; Herdman DS; DiScipio RG; Hugli TE; Gigli I
    J Immunol; 1995 Jul; 155(1):266-74. PubMed ID: 7602103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activation of complement and serial changes of anaphylatoxin (C3a, C5a) in patients for open-heart surgery using a membrane oxygenator].
    Mitsuhata H; Enzan K; Hasegawa J; Matumoto S; Matsumoto J; Kurosawa S
    Masui; 1992 Feb; 41(2):194-9. PubMed ID: 1552659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible Nitric Oxide Synthase (iNOS) Is a Novel Negative Regulator of Hematopoietic Stem/Progenitor Cell Trafficking.
    Adamiak M; Abdelbaset-Ismail A; Moore JB; Zhao J; Abdel-Latif A; Wysoczynski M; Ratajczak MZ
    Stem Cell Rev Rep; 2017 Feb; 13(1):92-103. PubMed ID: 27752990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ELMO1 is upregulated in AML CD34+ stem/progenitor cells, mediates chemotaxis and predicts poor prognosis in normal karyotype AML.
    Capala ME; Vellenga E; Schuringa JJ
    PLoS One; 2014; 9(10):e111568. PubMed ID: 25360637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISAs with monoclonal antibodies.
    Klos A; Ihrig V; Messner M; Grabbe J; Bitter-Suermann D
    J Immunol Methods; 1988 Jul; 111(2):241-52. PubMed ID: 3260926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cleavage of the third component of human complement (C3) by its small cleavage fragment, C3a: inhibition occurs with the classical-pathway, but not the alternative-pathway, C3 convertase.
    Strunk RC; Webster RO
    Mol Immunol; 1985 Jan; 22(1):37-43. PubMed ID: 3871899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of innate immunity in trafficking of hematopoietic stem cells-an emerging link between activation of complement cascade and chemotactic gradients of bioactive sphingolipids.
    Ratajczak MZ; Kim C; Wu W; Shin DM; Bryndza E; Kucia M; Ratajczak J
    Adv Exp Med Biol; 2012; 946():37-54. PubMed ID: 21948361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure.
    Lei YC; Lu CL; Chen L; Ge K; Yang LL; Li W; Wu YH
    World J Gastroenterol; 2016 Dec; 22(46):10148-10157. PubMed ID: 28028363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR7: a new SDF-1-binding receptor in contrast to normal CD34(+) progenitors is functional and is expressed at higher level in human malignant hematopoietic cells.
    Tarnowski M; Liu R; Wysoczynski M; Ratajczak J; Kucia M; Ratajczak MZ
    Eur J Haematol; 2010 Dec; 85(6):472-83. PubMed ID: 20887389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.